BD Switzerland Sàrl is part of the BD group and provides molecular diagnostics products, instruments and assays. Offerings include automated platforms such as the BD MAX™ System and BD COR™ System, and assays for infectious diseases and cervical cancer testing.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
✓ Offered10
Molecular diagnostic systems (BD MAX™ System)
Automated molecular platform for nucleic acid extraction and real-time PCR, with results for up to 24 samples and a broad menu of assays.
Automated high-throughput molecular diagnostic systems (BD COR™ System)
Modular automated platform for a complete molecular workflow, with integrated pre-analytics, processing of multiple assays and high throughput for screening.
Cervical cancer screening portfolio
Analysis and instrument solutions for cytology, HPV screening, co-testing and preparation/imaging of cervical samples.
HPV test (BD Onclarity™ HPV Assay)
DNA PCR assay for detection of HPV with extended genotyping, internal cellularity control and option for self-collected vaginal samples.
Liquid-based Pap test (BD SurePath™ Liquid-based Pap Test)
Vial and liquid-based Pap test for cervical cytology, with single sample collection for cytology, HPV co-testing and reflex tests.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.